6th Drug-Device Combination Products Conference - Kongress / Konferenz von Vonlanthen Group s.r.o

The 6th Drug-Device Combination Products Conference aims to address the critical importance of ensuring harmony between drug products and their delivery mechanisms. Particularly during the challenging initial phases of development when finalising formulations and dosage while navigating regulatory complexities - it presents significant hurdles to the successful advancement of sustainable and connected combined drug-device products.

The experts in drug delivery alongside device development engineers at the #VLDDCP summit will offer diverse perspectives on ensuring the compatibility and operational efficiency of drug products and delivery devices, exploring recent experience in the digital health, connected combination products and wearable injectors.

We are excited to introduce our esteemed speakers for The 6th Drug-Device Combination Products Conference, representing the forefront of pharmaceutical and medical device innovation. This exceptional lineup includes:

• Bjarne Sørensen, DKDirector, Front-End Innovation, Phillips-Medisize
• Dr. René Dathe, DEHead Quality Advanced Therapy Medicinal Products, Novartis
• Anne-Sofie Madsen Staples, DKInnovation Lead, Devices and Delivery Solutions, Novo Nordisk A/S
• Dr. William Denny, ATSenior Project Leader - Drug/Device Combination Products, Sandoz Device Development Centre
• Bernard Gauthier, FRGlobal Product Owner – GenMed Digital HealthCare, Sanofi
• Paul Johnson, UKManaging Director, Paul Johnson Consulting Limited
• Yvonne Limpens, NLManaging Human Factors Specialist, Emergo by UL
• Dr. Juan Martin Carriquiry, CHPartner & Head MDCP / Medical Devices & Combination Products, Beyond Conception GmbH
• Dr. Horacio M. Pace-Bedetti, DKPrincipal Usability Researcher, Novo Nordisk A/S
• Patrice Becker, FRGlobal Director Scientific Communications, St Gilesmedical London & Berlin
• Dr. Jakob Lange, CHHead of Account & Business Development, Ypsomed AG
• Dr. Javad Jabbari, DKRegulatory Affairs, Associate Director of Device and Combination Products, Ascendis Pharma
• Dr. Kevin Brunet, BEHead of Devices Development and Primary Packaging Quality, UCB
• Dr. Heather Johnson, UKSenior Consultant – Devices, Granzer Regulatory Consulting & Services GmbH

• Harmonising design controls with quality by design principles
• Determining device specifications during early development stages
• Assessing material compatibility and safety
• Navigating regulatory pathways and quality management systems
• Defining essential performance criteria
• Conducting design verification and validation
• Managing risk factors
• Ensuring device compliance and meeting essential performance standards
• Facilitating compatibility and clinical assessments
• Exploring sustainable and connected combination products and wearable injectors

• Assembling • Automation • Chemistry, Manufacturing and Controls (CMC) • Clean Room • Combination Products • Compatibility • Connected Devices • Connected Health • Connectivity • Design & Engineering • Design Architect • Device Development • Digital Health • Drug Delivery Systems (DDSs) • Drug Development • Drug Packaging • eHealth • Emulsions • Extractables and Leachables (E&L) • Filling Process • Filtration Process • Formulation • Glass • Good Manufacturing Practice (GMP) • Human Factors

6th Drug-Device Combination Products Conference

October 15-16, 2024

Hotel Riu Plaza Berlin  |  Martin-Luther-Str. 1  |  10777 Berlin, Germany 

The Delegate Pass include: 

• In person attendance for 2 days of the conference 
• Access to all speakers' presentations
• Networking sessions with all speakers and participants
• Refreshments & coffee breaks
• Lunch at the venue for both conference days
• Business dinner to polish the cooperation and networking
• After-event documentation package
• On-line & Off-line support from our team